Polyphyllin I induces rapid ferroptosis in acute myeloid leukemia through simultaneous targeting PI3K/SREBP-1/SCD1 axis and triggering of lipid peroxidation
- J Nat Med. 2024 Jun;78(3):618-632. doi: 10.1007/s11418-024-01811-4.
- 1. State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China.
- 2. College of Life Science, Liaocheng University, Liaocheng, 252059, China.
- 3. Department of Pharmacy, Panzhihua Central Hospital, Dali University, Panzhihua, China.
- 4. Department of Pharmacy, The Seventh People's Hospital of Chengdu, Chengdu, China.
- 5. State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China. [email protected].
- 6. School of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China. [email protected].
- 7. Department of Pharmacy, The Seventh People's Hospital of Chengdu, Chengdu, China. [email protected].
- 8. State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China. [email protected].
Acute myeloid leukemia (AML) is a malignant disease that is difficult to completely cure. Polyphyllin I (PPI), a steroidal saponin isolated from Paris polyphylla, has exhibited multiple biological activities. Here, we discovered the superior cytotoxicity of PPI on AML cells MOLM-13 with an IC50 values of 0.44 ± 0.09 μM. Mechanically, PPI could cause Ferroptosis via the accumulation of intracellular iron concentration and triggering lipid peroxidation. Interestingly, PPI could induced stronger Ferroptosis in a short time of about 6 h compared to erastin. Furthermore, we demonstrate that PPI-induced rapid Ferroptosis is due to the simultaneous targeting PI3K/SREBP-1/SCD1 axis and triggering lipid peroxidation, and PI3K Inhibitor Alpelisib can enhance the activity of erastin-induced Ferroptosis. Molecular docking simulations and kinase inhibition assays demonstrated that PPI is a PI3K Inhibitor. In addition, PPI significantly inhibited tumor progression and prolonged mouse survival at 4 mg/kg with well tolerance. In summary, our study highlights the therapeutic potential of PPI for AML and shows its unique dual mechanism.
-
Cat. No.Product NameDescriptionTargetResearch Area
-